FIELD: medicine, endocrinology.
SUBSTANCE: for osteoporosis treatment selective estrogen receptor modulator bazedoxifene is administered. Efficient treatment is ensured by introduction of said medication in doses from 5 mg to 400 mg according to schedule with long introduction intervals - from one time per two days to one time per week.
EFFECT: increase of treatment efficiency.
16 cl, 4 tbl, 3 ex
Authors
Dates
2009-05-20—Published
2003-06-13—Filed